TIDMCLON
RNS Number : 4292N
Clontarf Energy PLC
25 September 2023
25 September 2023
Clontarf Energy plc
("Clontarf" or the "Company")
Interim Statement for the period ended 30 June 2023
Clontarf Energy plc (AIM: CLON), the energy company focused on
Australia, Africa and Bolivia, announces its unaudited financial
results for the six months ended 30 June 2023:
Highlights
-- Formation of a comprehensive joint venture with breakthrough
Direct Lithium Extraction ("DLE") technology developers NEXT-ChemX
(the "JV").
-- Brine samples from five priority salares provided by the
Bolivian State Lithium Company for testing.
-- All samples successfully navigated the US Customs checks
without setbacks.
-- The JV's pilot plant components have now largely been
assembled at sub-contractor facilities.
-- Technical improvements including development and perfection
of state-of-the-art German-engineered sensors, to improve
performance.
-- Pilot plant construction, including assembly of innovative
components, will shortly be underway in Texas, after which testing
will begin.
-- Subject to test results and Bolivian laws, Clontarf plans to
run large-scale production testing to fine-tune the process.
-- Under applicable laws, the JV is ready to construct mobile
pilot plants to process brines at different salares in Bolivia and
neighbouring countries.
-- Clontarf has been invited to participate in European Union
initiatives to deliver battery-grade lithium salts to European
automotive, grid storage and mobile electronics industries.
-- The Bolivian authorities have adopted the suggestion to
conduct a bid-round on medium-sized salares, certain of which
Clontarf has reviewed and sampled.
-- Ratification discussions on Tano 2A block with Ghanaian
authorities continue - though the authorities have sought to
re-negotiate (to their benefit) at the acreage and fiscal terms
previously agreed. A new realism seems evident.
-- Further Australian drill targets are under consideration,
especially for gas to serve the dynamic liquified natural gas
("LNG") market.
Chairman's Statement
Recent months have witnessed accelerated field-work on several
fronts:
Clontarf teams have conducted further site-visits, sampling and
related geological work to deepen our understanding of
opportunities and challenges offered by the development of Direct
Lithium Extraction technologies.
Our primary focus has been working with the Bolivian
authorities, in accordance with applicable laws. This covers both
our work on Direct Lithium Extraction technologies, in joint
venture with NEXT-ChemX, as well as Clontarf's proposals to explore
and develop medium-sized salares. The Bolivian authorities have now
confirmed their plan to run a bid-round, as required by law and
proper governance, on these high-potential though under-explored
salt-lakes. This reflects a vision to develop the world's greatest
lithium resource as soon as feasible, to benefit local communities,
the authorities, as well as our partners, customers and the road to
energy transition.
Our JV partners have completed financings and sub-contractor
supply agreements on long-lead time and scarce components. Some
components are being enhanced in order to serve anticipated as well
as current customer needs. Remaining elements are being shipped to
site for final assembly, commissioning and testing.
This progress has brought us to the attention of the EU
Commission, as well as State-backed initiatives in Britain and the
USA. Clontarf has been invited to participate in a drive to explore
and develop lithium and other strategic minerals in northern
Argentina, and possibly other jurisdictions. We believe that such
timely initiatives may open larger and lower cost sources of equity
and debt financings. This would cut our cost of capital and open
many new opportunities for value added and expansion.
Subject to applicable laws, Clontarf has offered to participate
in a Bolivian Lithium opportunity in partnership with YLB using DLE
technology being developed by our technical partner, Next ChemX
Corporation.
Every brine is different, and we must ensure that the processing
parameters are compatible with the quantity, quality and other
parameters of the minerals that are present in the particular
brine. This is necessary in order to complete the design of the
larger commercial pilot plant specifically made for the selected
Bolivian brines.
With all necessary permits, we plan to collect and process
larger samples for pilot plant testing, including kinetics
calculations, flow-rates, etc.
The NEXT-ChemX process works directly from the brine, and after
a quick filtering to ensure there are no solids or debris in the
brine we feed into our system. We normally produce pure Lithium
Chloride, which we can then convert to battery grade Li(2) CO(3) or
LiOH - or possibly Lithium metal for solid state lithium
batteries.
This pilot plant testing will enable fine tuning of the process,
and determine recovery parameters, as well as operating cost
numbers applicable for different brine samples.
This work will help optimise output, demonstrating the
effectiveness of the Next ChemX technology and determining
throughput and recovery expected at in-situ pilot plants in South
America, and possibly elsewhere.
The mobile pilot plant will ideally run for 4 and 6 months, to
assess the potential of that location, after which the mobile pilot
plant can then be moved and reassembled at another salar. This
approach will enable customising of the DLE process for a variety
of brine grades and chemistries.
The Clontarf JV, in conjunction with the authorities, under
applicable laws, plans to build a full scale processing plant of an
agreed capacity to extract production tonnages of Lithium
Carbonate, or other desired form of Lithium. We would also assess
the viability for the recovery of calcium, magnesium, and potassium
chlorides at each location showing attractive flow volumes and
recoverable grade. The overall capacity will be scalable via
deployment of modular units over a period of months to years.
Each plant can be upgraded to produce value added production,
i.e. lithium chloride to lithium carbonate, lithium hydroxide and,
if feasible, lithium metal. A similar approach to boosting value
added will be implemented for other, economic non-lithium minerals,
such as magnesium and potassium.
In oil and gas, the tightening hydrocarbons' supply-demand
balance promises a long-overdue revival of exploration and the
farm-out market. Shortages of piped gas and LNG feedstock have
strengthened long-term prices. The centrality of LNG to fuel any
energy transition in Europe and Asia has now been broadly accepted
- except for fringe elements - and even by previous sceptics. There
can be no reliance on intermittent renewables generation without
reliable back-up.
The resurgence of interest in African exploration and
development may lead to additional proposals in the coming months.
Clontarf continues to insist on strict adherence to our ESG
standards.
Clontarf therefore progresses its interests in Bolivia,
Australia, Chad and Ghana, maintaining cordial communications with
the relevant authorities, and continues to operate efficiently on
minimal expenditure.
Funding
Subject to technical verification of its exploration projects,
and permitting, Clontarf is confident of securing adequate funding,
whether in London or Australia, for near to medium term ongoing
activities.
We set out to reduce political and geological risks.
Fortune favours the brave. The best is yet to come.
David Horgan
Chairman
22(nd) September 2023
This announcement contains inside information for the purposes
of Article 7 of Regulation (EU) 596/2014.
S
For further information please visit http://clontarfenergy.com
or contact:
Clontarf Energy
David Horgan, Chairman
Jim Finn, Director +353 (0) 1 833 2833
Nominated & Financial Adviser
Strand Hanson Limited
Rory Murphy
Ritchie Balmer +44 (0) 20 7409 3494
Broker
Novum Securities Limited
Colin Rowbury +44 (0) 207 399 9400
Public Relations
BlytheRay
Megan Ray +44 (0) 207 138 3206
Teneo
Luke Hogg
Alan Tyrrell +353 (0) 1 661 4055
CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME
Six Months Ended Year Ended
30 June 23 30 June 22 31 Dec 22
unaudited unaudited audited
GBP'000 GBP'000 GBP'000
Administrative
expenses (288) (414) (672)
Impairment of
exploration
and evaluation
assets - (4,095) (4,095)
----------------------------------------- ------------------------------------------ -------------------------------------------
LOSS BEFORE
TAXATION (288) (4,509) (4,767)
Income Tax - - -
----------------------------------------- ------------------------------------------ -------------------------------------------
COMPREHENSIVE
INCOME FOR THE
PERIOD (288) (4,509) (4,767)
========================================= ========================================== ===========================================
LOSS PER SHARE
- basic and
diluted (0.01p) (0.34p) (0.26p)
========================================= ========================================== ===========================================
CONDENSED
CONSOLIDATED
BALANCE SHEET
30 June 23 30 June 22 31 Dec 22
unaudited unaudited audited
GBP'000 GBP'000 GBP'000
ASSETS:
NON-CURRENT
ASSETS
Intangible
assets 1,756 868 868
1,756 868 868
----------------------------------------- ------------------------------------------ -------------------------------------------
CURRENT ASSETS
Other
receivables - 1 -
Cash and cash
equivalents 381 188 932
----------------------------------------- ------------------------------------------ -------------------------------------------
381 189 932
TOTAL ASSETS 2,137 1,057 1,800
----------------------------------------- ------------------------------------------ -------------------------------------------
LIABILITIES:
CURRENT
LIABILITIES
Trade and other
liabilities (1,512) (2,088) (3,027)
----------------------------------------- ------------------------------------------ -------------------------------------------
(1,512) (2,088) (3,027)
----------------------------------------- ------------------------------------------ -------------------------------------------
TOTAL
LIABILITIES (1,512) (2,088) (3,027)
NET ASSETS /
(LIABILITIES) 625 (1,031) (1,227)
========================================= ========================================== ===========================================
EQUITY
Called-up share
capital 6,209 5,927 5,927
Share premium 12,737 10,985 10,985
Share based
payment
reserve 354 186 248
Retained
deficit (18,675) (18,129) (18,387)
----------------------------------------- ------------------------------------------ -------------------------------------------
TOTAL EQUITY 625 (1,031) (1,227)
========================================= ========================================== ===========================================
CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY
Called-up Share based
Share Share Payment Retained
Capital Premium Reserves Deficit Total
GBP'000 GBP'000 GBP'000 GBP'000 GBP'000
As at 1
January 2022 2,177 10,985 186 (13,620) (272)
Shares issued 3,750 - - - 3,750
Total
comprehensive
income - - - (4,509) (4,509)
--------------------------------------- --------------------------------------- ----------------------------------------- ------------------------------------------ ----------------------------------------
As at 30 June
2022 5,927 10,985 186 (18,129) (1,031)
Share based
payment charge - - 62 - 62
Total
comprehensive
income - - - (258) (258)
--------------------------------------- --------------------------------------- ----------------------------------------- ------------------------------------------ ----------------------------------------
As at 31
December 2022 5,927 10,985 248 (18,387) (1,227)
Shares issued 282 1,849 - - 2,131
Share issue
expenses - (97) - - (97)
Share based
payment charge - - 106 - 106
Total
comprehensive
income - - - (288) (288)
-----------------------------------------
As at 30 June
2023 6,209 12,737 354 (18,675) 625
======================================= ======================================= ========================================= ========================================== ========================================
CONDENSED
CONSOLIDATED CASH
FLOW Six Months Ended Year Ended
30 June 23 30 June 22 31 Dec 22
unaudited unaudited audited
GBP'000 GBP'000 GBP'000
CASH FLOW USED IN
OPERATING ACTIVITIES
Loss for the period (288) (4,509) (4,767)
Impairment of
exploration and
evaluation assets - 4,095 4,095
Share based payment
charge 106 - 62
Exchange movements 2 1 3
----------------------------------------- ------------------------------------------ ------------------------------------------
(180) (413) (607)
----------------------------------------- ------------------------------------------ ------------------------------------------
Movements in working
capital
Decrease in other
receivables - 2 2
(Decrease)/Increase
in trade and other
payables (1,516) 601 1,541
----------------------------------------- ------------------------------------------ ------------------------------------------
(1,516) 603 1,543
----------------------------------------- ------------------------------------------ ------------------------------------------
NET CASH USED IN
OPERATING
ACTIVITIES (1,696) 190 936
----------------------------------------- ------------------------------------------ ------------------------------------------
CASH FLOWS USED IN
INVESTING ACTIVITIES
Payments for
intangible assets (406) (4,095) (4,095)
NET CASH USED IN
INVESTING
ACTIVITIES (406) (4,095) (4,095)
----------------------------------------- ------------------------------------------ ------------------------------------------
CASH FLOW FROM
FINANCING ACTIVITIES
Issue of shares 1,650 3,750 3,750
Share issue expenses (97) - -
----------------------------------------- ------------------------------------------ ------------------------------------------
NET CASH GENERATED
FROM FINANCING
ACTIVITIES 1,553 3,750 3,750
----------------------------------------- ------------------------------------------ ------------------------------------------
NET
(DECREASE)/INCREASE
IN CASH AND CASH
EQUIVALENTS (549) (155) 591
Cash and cash
equivalents at
beginning of the
period 932 344 344
Exchange loss on
cash and cash
equivalents (2) (1) (3)
CASH AND CASH
EQUIVALENT AT THE OF THE PERIOD 381 188 932
========================================= ========================================== ==========================================
Notes:
1. INFORMATION
The financial information for the six months ended 30 June 2023
and the comparative amounts for the six months ended 30 June 2022
are unaudited. The financial information above does not constitute
full statutory accounts within the meaning of section 434 of the
Companies Act 2006.
The Interim Financial Report has been prepared in accordance
with IAS 34 Interim Financial Reporting as adopted by the U.K. The
accounting policies and methods of computation used in the
preparation of the Interim Financial Report are consistent with
those used in the Group 2022 Annual Report, which is available at
www.clontarfenergy.com
The interim financial statements have not been audited or
reviewed by the auditors of the Group pursuant to the Auditing
Practices board guidance on Review of Interim Financial
Information.
2. DIVID
No dividend is proposed in respect of the period.
3. GOING CONCERN
The Group incurred a loss for the period of GBP288,472 (2022:
GBP4,766,646) and had net current liabilities of GBP1,130,220
(2022: GBP2,094,612) at the balance sheet date. These conditions,
as well as those noted below, represent a material uncertainty that
may cast doubt on the Group's ability to continue as a going
concern.
Included in current liabilities is an amount of GBP1,450,565
(2022: GBP1,525,565) owed in respect of Directors' remuneration due
at the balance sheet date. The Directors have confirmed that they
will not seek settlement of these amounts in cash until after the
end of 2024.
The Group had a cash balance of GBP381,420 (2022: GBP931,902) at
the balance sheet date. As the Group is not revenue or cash
generating it relies on raising capital from the public market. On
16 January 2023 the Group raised GBP1,300,000 on a placing and a
further GBP350,000 on 1 June 2023. Further information is detailed
in Note 7 below.
As in previous years the Directors have given careful
consideration to the appropriateness of the going concern basis in
the preparation of the financial statements and believe the going
concern basis is appropriate for these financial statements. The
financial statements do not include the adjustments that would
result if the Group and Company were unable to continue as a going
concern.
4. LOSS PER SHARE
Basic loss per share is computed by dividing the loss after
taxation for the year attributable to ordinary shareholders by the
weighted average number of ordinary shares in issue and ranking for
dividend during the year. Diluted earnings per share is computed by
dividing the loss after taxation for the year by the weighted
average number of ordinary shares in issue, adjusted for the effect
of all dilutive potential ordinary shares that were outstanding
during the year.
The following table sets out the computation for basic and
diluted earnings per share ("EPS"):
Six Months Ended Year Ended
30 June 23 30 June 22 31 Dec 22
GBP'000 GBP'000 GBP'000
Loss for the
year
attributable
to equity
holders (288) (4,509) (4,767)
================================== ================================== ==================================
Denominator Number Number Number
For basic and
diluted EPS 4,385,660,371 1,328,908,309 1,856,031,596
================================== ================================== ==================================
Basic and
diluted EPS (0.01p) (0.34p) (0.26p)
================================== ================================== ==================================
Basic and diluted loss per share are the same as the effect of
the outstanding share options is anti-dilutive and is therefore
excluded.
5. INTANGIBLE ASSETS
30 June 30 June 31 Dec
23 22 22
GBP'000 GBP'000 GBP'000
Exploration
and
evaluation
assets
Cost:
At 1 January 12,735 8,640 8,640
Additions 888 4,095 4,095
Closing
Balance 13,623 12,735 12,735
============================ ============================ ============================
Impairment:
At 1 January 11,867 7,772 7,772
Provision
for
impairment - 4,095 4,095
Closing
Balance 11,867 11,867 11,867
============================ ============================ ============================
Carrying
value:
At 1 January 868 868 868
============================ ============================ ============================
At period
end 1,756 868 868
============================ ============================ ============================
Regional 30 Jun 30 Jun 31
Analysis 23 22 Dec22
GBP'000 GBP'000 GBP'000
Bolivia - 888 - -
Investment
in JV
Ghana 868 868 868
---------------------------- ---------------------------- ----------------------------
1,756 868 868
============================ ============================ ============================
Exploration and evaluation assets relate to expenditure incurred
in prospecting and exploration for lithium, oil and gas in Bolivia
and Ghana. The Directors are aware that by its nature there is an
inherent uncertainty in exploration and evaluation assets and
therefore inherent uncertainty in relation to the carrying value of
capitalised exploration and evaluation assets.
During 2018 the Group resolved the outstanding issues with the
Ghana National Petroleum Company ("GNPC") regarding a contract for
the development of the Tano 2A Block. The Group has signed a
Petroleum Agreement in relation to the block and this agreement
awaits ratification by the Ghanian government.
The Company is in negotiations with the Vice-Ministry of
Electrical Technologies and the State Lithium Company in Bolivia on
exploration and development of salt-lakes in accordance with law.
Samples have been analysed and process work is underway.
On 15 February 2023 the Company announced a heads of agreement
around the potential formation of a 50:50 Joint Venture with US
based, OTC Markets traded, technology company, NEXT-ChemX
Corporation ("NCX") covering testing, marketing, and deploying of
NCX's proprietary (patent pending) direct lithium ion extraction
("DLE") technology in Bolivia. Formation of the JV was subject to
final due diligence and the parties entering into formal
documentation.
On 5 May 2023 the Company announced that all conditions
precedent had been satisfied with respect to the JV with NEXT-ChemX
coming into force. In this regard, Clontarf paid NEXT-ChemX
Corporation US$500,000 and has issued to NEXT-ChemX 385 million new
Ordinary Shares in the capital of Clontarf of which half are
subject to a 12-month lock in requirement.
The Directors believe that there were no facts or circumstances
indicating that the carrying value of intangible assets may exceed
their recoverable amount and thus no impairment review was deemed
necessary by the Directors. The realisation of these intangibles
assets is dependent on the successful discovery and development of
economic deposit resources and the ability of the Group to raise
sufficient finance to develop the projects. It is subject to a
number of potential significant risks, as set out below.
The Group's activities are subject to a number of significant
potential risks including:
-- licence obligations;
-- exchange rate risks;
-- uncertainties over development and operational costs;
-- political and legal risks, including agreements with
Governments for licences, profit sharing and taxation;
-- foreign investment risks including increases in taxes,
royalties and renegotiation of contracts;
-- title to assets;
-- financial risk management;
-- going concern; and
-- ability to raise finance.
6. TRADE AND OTHER PAYABLES
30 June 30 June 31 Dec
23 22 22
GBP'000 GBP'000 GBP'000
Creditor
-
Western
Gas - 550 553
Trade
payables 35 48 57
Other
payables 1,451 1,480 1,526
Cash
received
in
advance
of share
placing - - 870
Related
parties 13 - 5
Other
accruals 12 10 16
---------------------------- ---------------------------- ----------------------------
1,511 2,088 3,027
============================ ============================ ============================
Other payables relate to amounts due to Directors and a former
Director for remuneration accrued but not paid at period end.
7. SHARE CAPITAL
Deferred Shares - nominal value of 0.24p
Number Share Capital Share Premium
GBP'000 GBP'000
At 1 January 2022 - - -
-------------- -------------- --------------
At 30 June 2022 - - -
Transfer from ordinary shares 2,370,826,117 5,690 -
-------------- -------------- --------------
At 31 December 2022 and 30 June 2023 2,370,826,117 5,690 -
============== ============== ==============
Ordinary Shares - nominal value of 0.01p
Allotted, called-up and fully paid:
Number Share Capital Share Premium
GBP'000 GBP'000
At 1 January 2022 870,826,117 2,177 10,985
Issued during the period 1,500,000,000 3,750 -
At 30 June 2022 2,370,826,117 5,927 10,985
Transfer to deferred shares (5,690) -
-------------- -------------- --------------
At 31 December 2022 2,370,826,117 237 10,985
Issued during the period 2,822,500,000 282 1,849
Share issue expenses - - (97)
-------------- -------------- --------------
At 30 June 2023 5,193,326,117 519 12,737
============== ============== ==============
On 4 August 2022 the 2,370,826,117 issued ordinary shares of
0.25p each were subdivided via ordinary resolution into
2,370,826,117 ordinary shares of 0.01p each and 2,370,826,117
deferred shares of 0.24p each.
Movements in issued share capital
On 16 January 2023 the Company raised GBP1,300,000 via a placing
of 2 billion new ordinary shares of 0.01p each, via several
Australian based brokers, at a price of 0.065p per share. In
connection with the placing 97,500,000 warrants were issued to the
brokers involved in the placing. Further information is detailed in
Note 8 below. The proceeds were used to advance the Company's
lithium projects in Bolivia, and petroleum projects in Ghana,
Australia, and elsewhere.
On 5 May 2023 as part of the Joint Venture agreement with
NEXT-ChemX the Company issued 385 million ordinary shares of 0.01p
each at a price of 0.125p to NEXT-ChemX. Further information is
detailed in Note 5 above.
On 1 June 2023 the Company raised GBP350,000 via a placing of
437,500,000 ordinary shares of 0.01p each at a price of 0.08p per
share. Proceeds raised will be used to provide additional working
capital and fund developments costs.
8. SHARE BASED PAYMENTS
SHARE OPTIONS
The Group issues equity-settled share-based payments to certain
Directors and individuals who have performed services for the
Group. Equity-settled share-based payments are measured at fair
value at the date of grant.
Fair value is measured by the use of a Black-Scholes model.
The Group plan provides for a grant price equal to the average
quoted market price of the ordinary shares on the date of
grant.
30 Jun 23 30 Jun 22 31 Dec22
Options Weighted Options Weighted Options Weighted
Number average Number average Number average
'000 exercise '000 exercise '000 exercise
price in price in price in
pence pence pence
At 1 January 40,500 0.7 40,500 0.7 40,500 0.7
Issued 160,000 0.0725 - -
---------------------------- ----------------------------- ---------------------------- ----------------------------- ---------------------------- -----------------------------
Outstanding
at end of
period 200,500 0.20 40,500 0.7 40,500 0.7
---------------------------- ----------------------------- ---------------------------- ----------------------------- ---------------------------- -----------------------------
Exercisable
at end of
period 200,500 0.20 30,500 0.7 40,500 0.7
============================ ============================= ============================ ============================= ============================ =============================
On 17 January 2023 a total of 160,000,000 options were granted
with a fair value of GBP106,632 to Directors and individuals who
have performed services for the Group. These fair values were
calculated using the Black-Scholes valuation model.
The inputs into the Black-Scholes valuation model were as
follows:
Grant 17 January 2023
Weighted average share price at date of grant (in pence) 0.07p
Weighted average exercise price (in pence) 0.0725p
Expected volatility
144.39%
Expected life
7 years
Interest free rate
5%
Expected dividends none
Expected volatility was determined by management based on their
cumulative experience of the movement in share prices. The terms of
the options granted do not contain any market conditions within the
meaning of IFRS 2.
The Group capitalised expenses of GBPNil (2022: GBPNil) and
expensed costs of GBP106,632 (2022: GBP61,695) relating to
equity-settled share-based payment transactions during the
year.
Warrants
30 Jun 23 30 Jun 22 31 Dec22
Warrants Weighted Warrants Weighted Warrants Weighted
Number average Number average Number average
'000 exercise '000 exercise '000 exercise
price in price in price in
pence pence pence
At 1 January 435,683 0.25 - - - -
Issued 97,500 0.065 435,683 0.25 435,683 0.25
----------------------------- ----------------------------- ----------------------------- ----------------------------- ----------------------------- -----------------------------
Exercisable
at end of
period 533,183 0.22 435,683 0.25 435,683 0.25
============================= ============================= ============================= ============================= ============================= =============================
On 16 January 2023 in connection with the share placing a total
of 97,500,000 warrants were issued to the brokers involved with the
placing. The warrants have an exercise price of 0.065p.
9. POST BALANCE SHEET EVENTS
On 1 August 2023 the Company announced that the following
long-term, incentive share options have been granted over, in
aggregate, 300,000,000 ordinary shares of 0.01p each in the
Company. The Options vest immediately, have an exercise price of
0.10p and an expiry date of 30th July 2030.
The Options have been awarded as follows:
Number of Options Granted
David Horgan 115,000,000
James Finn 75,000,000
Peter O'Toole 75,000,000
Dipti Mehta 35,000,000
10. The Interim Report for the six months to 30 June 2023 was
approved by the Directors on 22 September 2023.
11. The Interim Report will be available on the Company's
website at www.clontarfenergy.com .
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
IR PPUUUBUPWGMP
(END) Dow Jones Newswires
September 25, 2023 02:00 ET (06:00 GMT)
Clontarf Energy (LSE:CLON)
Historical Stock Chart
From Oct 2024 to Nov 2024
Clontarf Energy (LSE:CLON)
Historical Stock Chart
From Nov 2023 to Nov 2024
